Xmt-2056
Non-Small Cell Lung Carcinoma
Explore 1,125 assets in Non-Small Cell Lung Carcinoma →Day One Biopharmaceuticals, Inc.UNKNOWNPhase 1
—
Rating in progress
Xmt-2056 in Non-Small Cell Lung Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active